{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-13",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "37000-517",
      "generic_name": "Acetaminophen, Phenylephine HCl, Dextromethorphan Hydrobromide, and Guaifenesin",
      "labeler_name": "The Procter & Gamble Manufacturing Company",
      "brand_name": "Vicks DayQuil Severe Cold and Flu",
      "brand_name_suffix": "Cold and Flu",
      "active_ingredients": [
        {
          "name": "PHENYLEPHRINE HYDROCHLORIDE",
          "strength": "5 mg/1"
        },
        {
          "name": "ACETAMINOPHEN",
          "strength": "325 mg/1"
        },
        {
          "name": "DEXTROMETHORPHAN HYDROBROMIDE",
          "strength": "10 mg/1"
        },
        {
          "name": "GUAIFENESIN",
          "strength": "200 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "37000-517-02",
          "description": "2 CAPSULE, LIQUID FILLED in 1 POUCH (37000-517-02)",
          "marketing_start_date": "20210101",
          "sample": false
        },
        {
          "package_ndc": "37000-517-08",
          "description": "1 BLISTER PACK in 1 CARTON (37000-517-08)  / 8 CAPSULE, LIQUID FILLED in 1 BLISTER PACK",
          "marketing_start_date": "20190701",
          "sample": false
        },
        {
          "package_ndc": "37000-517-16",
          "description": "2 BLISTER PACK in 1 CARTON (37000-517-16)  / 8 CAPSULE, LIQUID FILLED in 1 BLISTER PACK",
          "marketing_start_date": "20180710",
          "sample": false
        },
        {
          "package_ndc": "37000-517-24",
          "description": "2 BLISTER PACK in 1 CARTON (37000-517-24)  / 12 CAPSULE, LIQUID FILLED in 1 BLISTER PACK",
          "marketing_start_date": "20180710",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "CAPSULE, LIQUID FILLED",
      "spl_id": "5d18ffb3-3e79-be19-e063-6394a90a046e",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20180710",
      "product_id": "37000-517_5d18ffb3-3e79-be19-e063-6394a90a046e",
      "application_number": "M012",
      "brand_name_base": "Vicks DayQuil Severe",
      "pharm_class": [
        "Adrenergic alpha1-Agonists [MoA]",
        "Decreased Respiratory Secretion Viscosity [PE]",
        "Expectorant [EPC]",
        "Increased Respiratory Secretions [PE]",
        "Sigma-1 Agonist [EPC]",
        "Sigma-1 Receptor Agonists [MoA]",
        "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]",
        "Uncompetitive NMDA Receptor Antagonists [MoA]",
        "alpha-1 Adrenergic Agonist [EPC]"
      ]
    }
  ]
}